Jeffries sell side merger and acquisition their main product including big pharm from their web site
Completed over 250 M&A transactions with deal value of over $145 billion since the beginning of 2011
M&A is the largest product area at Jefferies, representing approximately 50% of investment banking revenue1
Highest percentage of sole-advised M&A transactions of any major investment bank2
One of Wall Street's leading sell-side advisors: Approximately 70% of our M&A transactions are sell-side transactions
Approximately 75% of sale assignments completed with strategic acquirers
Over 35% of sale assignments completed with cross-border counterparties
Since 2011, mean EV/EBITDA multiple of 13.5x achieved for Jefferies' public company sell-side clients versus 9.6x for the overall public sell-side market
2011 M&A Deal of the Year awarded by The Deal magazine: Jefferies acted as sole financial advisor to Samson Investment Company in the $7.2 billion sale to an investor group led by KKR
2011 Deal of the Year by the New York Times’ DealBook: Jefferies acted as sole financial advisor to iGATE Corporation in the $1.5 billion acquisition of Patni Computer Systems
If you think NAVB is such a 'POS", why do continue to hang around and post? I have an idea. Unless you have something positive and factual to say, why don't you toss out the bong, move out of your mom's house and get a job!
Meeting with Jefferies and Co. is always a welcome news even the company is not for sale. Every company should have that open option for merger, acquition and be valued from time to time. Merging with another company with income and consolodate expense should always be on the table.
Jefferies Global Healthcare Conference June 3-6-gathering of institutional/private equity investors, VCs and leading executives
Jefferies 2013 Global Healthcare Conference
June 3 - 6, 2013
New York City
We are pleased to announce the Jefferies 2013 Global Healthcare Conference taking place June 3-6 in New York City.
Following the success of last year’s conference, with over 300 presenting companies and 2,000 attendees, the 2013 conference will again feature an extensive range of public & private healthcare companies across the biopharmaceuticals, life sciences, healthcare services, healthcare IT and medical technology sectors.
The four day event will be comprised of concurrent tracks of company presentations as well as Q&A breakout sessions, investor meetings, business-to-business meetings and thematic panel discussions. This global gathering of institutional investors, private equity investors, VCs and leading executives will address near- and long-term investment opportunities and discuss the mechanisms driving healthcare in the U.S. and internationally.
You must have a Jefferies representative in order to register."